news and events
ClinDatrix provided full service for the successful Phase 3 study of the following contact lens for Bausch + Lomb:
Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication
We look forward to meeting with you in person – at your office or ours, or at an upcoming industry conference.
Events
| Jun 24-28, 2018 | DIA, Boston, MA |
| Sep 12-13, 2018 | Outsourcing in Clinical Trials Midwest, Chicago, IL |
| Sep 26-27, 2018 | Outsourcing in Clinical Trials Southern California, La Jolla, CA |